{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:51:35Z","timestamp":1790297495518,"version":"4.1.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aims to evaluate the use of STOPP\/START criteria in the identification of Potentially inappropriate medication and potential prescribing omissions in older patients with cardiovascular diseases in Bulgaria. Excessive morbidity and mortality has been linked to drug-related problems and increased use of healthcare services and is an understudied problem for Bulgaria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>A prospective, questionnaire-based study was conducted among 543 older patients across 25 pharmacies in Bulgaria. Socio-demographic characteristic, disease profile, symptoms, and medication data were collected. The questionnaire was developed for the purposes of the EUROAGEISM project. Out of all 543 patients, only those with documented cardio-vascular diseases were extracted and the medication profile per patient was evaluated for Potentially inappropriate medication (PIMs) and potentially prescribing omissions (PPOs) using STOPP\/START criteria version 2. In addition, several risks for potentially inappropriate prescribing (PIPs), PPOs and PIMs were calculated with the focus being on the Odds and Risks to develop a PIP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Four hundred and twenty eight from 531 patients with known therapy for cardiovascular diseases (CVDs) were included in the analysis of PIP (40.52% aged 65\u201369 years, 61.88% female, 64% had up to 6 comorbidities, and 21.72% presenting with polypharmacy). A total of 71 PIMs in 64 patients with polypharmacy were identified during applying STOPP criteria. 56% of patients taking above five medicines daily had PIMs. The majority of PIMs (31%) were related to CVDs treatment, followed by PIMs in the treatment of endocrine diseases (22.54%), duplication of medicines (8.46%) and prolonged treatment with benzodiazepines (8.46%). Forty four PPOs were identified with START criteria. 22.72% were related to lack of proton pump inhibitors (PPI) in the presence of gastroesophageal disorders, and the same percentage was for lack of Calcium-vitamin D supplementation in osteoporosis. Applying the methodology of risks calculation the sample risk for PPO was 2.1% and for PIM 3.4%. At sample level the relative risk for PPO was 62% out of the risk for PIM and at population level varied between 42.8 and 89.8% and it is statistically significant. The number needed to treat for the event to happen is 77.5, meaning that at every 78 prescriptions there is a chance to appear PIP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Application of methodologies for detection of potentially inappropriate prescribing is not part of routine clinical practice in Bulgaria. Our study demonstrates a high percentage of potentially inappropriate medication among older patients with polypharmacy. Along with the aging population in Bulgaria, economic burden of polypharmacy and the prevalence of cardiovascular diseases, it is especially important to address potentially inappropriate medication use in cardiovascular patients. There is a considerable necessity for implementation of measures for early detection of potentially inappropriate medication and potentially prescribing omission as a part of de-prescribing strategies in older patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.1023171","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T10:25:27Z","timestamp":1671704727000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of potentially inappropriate medication in older patients with cardiovascular diseases\u2014STOPP\/START-based study"],"prefix":"10.3389","volume":"10","author":[{"given":"Tzvetan","family":"Krustev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petya","family":"Milushewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Tachkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Mitov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenka","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12875-017-0642-0","article-title":"Current and future perspectives on the management of polypharmacy","volume":"18","author":"Molokhia","year":"2017","journal-title":"BMC FAM Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1067\/mem.2001.119456","article-title":"Polypharmacy, adverse drug-related events, and potential adverse drug interactions in older patients presenting to an emergency department","volume":"38","author":"Hohl","year":"2001","journal-title":"Ann Emerg Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.clpt.6100035","article-title":"Anticholinergic drugs and physical function among frail older population","volume":"81","author":"Landi","year":"2007","journal-title":"Clin Pharmacol Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2042098615615472","article-title":"Predicting risk of adverse drug reactions in older adults","volume":"7","author":"Lavan","year":"2016","journal-title":"Ther Adv Drug Saf."},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jcdd6020019","article-title":"Cardiovascular risks associated with gender and aging","volume":"6","author":"Rodgers","year":"2019","journal-title":"J Cardiovasc Dev Dis."},{"key":"B6","unstructured":"2022"},{"key":"B7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0140-6736(07)61091-5","article-title":"Appropriate prescribing in older people: how well can it be measured and optimised?","volume":"370","author":"Spinewine","year":"2007","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O'Mahony","year":"2014","journal-title":"Age Ageing."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00228-011-1061-0","article-title":"Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals","volume":"67","author":"Gallagher","year":"2011","journal-title":"Eur J Clin Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/17512433.2020.1697676","article-title":"STOPP\/START criteria for potentially inappropriate medication\/potential prescribing omissions in older people: origin and progress","volume":"13","author":"O'Mahony","year":"2020","journal-title":"Expert Rev Clin Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1345\/aph.1D182","article-title":"Drug-related problem classification systems","volume":"38","author":"Van Mil","year":"2004","journal-title":"Ann Pharmacother."},{"key":"B12","unstructured":"An international, multi-disciplinary, multi-sectoral training network on ageism\n            ComissionEuropeene"},{"key":"B13","first-page":"3","volume-title":"Global Atlas on Cardiovascular Disease Prevention and Control (PDF)","author":"Shanthi","year":"2011"},{"key":"B14","unstructured":""},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-021-02715-8","article-title":"Factors associated to potentially inappropriate prescribing in older patients according to STOPP\/START criteria: MoPIM multicentre cohort study","author":"Bar\u00e9","year":"2022","journal-title":"BMC Geriatr 22, 44."},{"key":"B16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11096-017-0452-4","article-title":"Evaluating the prevalence of potentially inappropriate prescribing in older adults in intermediate care facilities: a cross-sectional observational study","volume":"39","author":"Millar","year":"2017","journal-title":"Int J Clin Pharm"},{"key":"B17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/ageing\/afw243","article-title":"Potentially inappropriate prescribing to older patients in primary care in the Netherlands: a retrospective longitudinal study","volume":"46","author":"Bruin-Huisman","year":"2017","journal-title":"Age Ageing."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e13428","DOI":"10.1111\/ijcp.13428","article-title":"Potential prescribing omissions in patients with cardiovascular disease","author":"Murillo-Mu\u00f1oz","year":"2019","journal-title":"Int J Clin Pract"},{"key":"B19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF03319100","article-title":"Explicit criteria for potentially inappropriate medications to reduce the risk of adverse drug reactions in elderly people: from Beers to STOPP\/START criteria","volume":"35","author":"Corsonello","year":"2012","journal-title":"Drug Saf"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1111\/bcp.14870","article-title":"Potentially inappropriate prescribing and its associations with health-related and system-related outcomes in hospitalised older adults: a systematic review and meta-analysis","volume":"87","author":"Mekonnen","year":"2021","journal-title":"Br J Clin Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","article-title":"Evidence based medicine: what it is and what it isn't","volume":"312","author":"Sackett","year":"1996","journal-title":"BMJ"},{"key":"B22","year":"2019"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e034441","DOI":"10.1136\/bmjopen-2019-034441","article-title":"Multimorbidity patterns in low-middle and high income regions: a multiregion latent class analysis using ATHLOS harmonized cohorts","volume":"10","author":"Bayes-Marin","year":"2020","journal-title":"BMJ Open."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e83783","DOI":"10.1371\/journal.pone.0083783","article-title":"Multimorbidity and comorbidity of chronic diseases among the senior Australians: prevalence and patterns","volume":"9","author":"Islam","year":"2014","journal-title":"PLoS ONE"},{"key":"B25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1472-6963-10-111","article-title":"Prevalence estimates of multimorbidity: a comparative study of two sources","volume":"10","author":"Fortin","year":"2010","journal-title":"BMC Health Serv Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1001\/archinte.162.20.2269","article-title":"Prevalence, expenditures, and complications of multiple chronic conditions in the older","volume":"162","author":"Wolff","year":"2002","journal-title":"Arch Intern Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","article-title":"Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs","volume":"176","author":"Qato","year":"2016","journal-title":"JAMA Intern Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamainternmed.2015.8597","article-title":"Polypharmacy-time to get beyond numbers","volume":"176","author":"Steinman","year":"2016","journal-title":"JAMA Intern Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/jamainternmed.2015.8593","article-title":"Non-disclosure of complementary and alternative medicine use to primary care physicians: findings from the 2012 national health interview survey","volume":"176","author":"Jou","year":"2016","journal-title":"JAMA Intern Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/jcpt.12494","article-title":"The use of potentially inappropriate medications among the Lithuanian older according to Beers and EU (7)-PIM list - a nationwide cross-sectional study on reimbursement claims data","volume":"42","author":"Grina","year":"2017","journal-title":"J Clin Pharm Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults","volume":"63","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"B32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","article-title":"The EU (7)-PIM list: a list of Potentially inappropriate medication for older people consented by experts from seven European countries","volume":"71","author":"Renom-Guiteras","year":"2015","journal-title":"Eur J Clin Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/qjmed\/hct141","article-title":"The impact of number of drugs prescribed on the risk of potentially inappropriate medication among outpatient older adults with chronic diseases","volume":"106","author":"Weng","year":"2013","journal-title":"QJM Int J Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"743138","DOI":"10.3389\/fpubh.2022.743138","article-title":"Impact of polypharmacy, drug-related problems, and potentially inappropriate medication in geriatric patients and its implications for Bulgaria-narrative review and meta-analysis","volume":"10","author":"Krustev","year":"2022","journal-title":"Front Public Health."},{"key":"B35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2298\/VSP200623118S","article-title":"Potentially inappropriate medication prescribing among elderly older patients with cardiovascular diseases","volume":"79","author":"Stojanovic","year":"2022","journal-title":"Vojnosanitetski pregled."},{"key":"B36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4321\/S1886-36552012000200004","article-title":"Potentially inappropriate prescribing in institutionalized older patients in Spain: the STOPP-START criteria compared with the Beers criteria","volume":"10","author":"Ubeda","year":"2012","journal-title":"Pharm Pract."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1590\/1806-9282.66.8.1087","article-title":"Risk factors associated with potential cardiovascular and cerebrovascular adverse events in elderly individuals assisted at secondary level","volume":"66","author":"Oliveira","year":"2020","journal-title":"Rev Assoc Med Bras"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.3390\/jcm9113728","article-title":"The burden of potentially inappropriate medications in chronic polypharmacy","volume":"9","author":"Guillot","year":"2020","journal-title":"J Clin Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1111\/bcp.14685","article-title":"Trends in polypharmacy and potentially inappropriate medication (PIM) in older and middle-aged people treated for diabetes","volume":"87","author":"Oktora","year":"2021","journal-title":"Br J Clin Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/medicina55070332","article-title":"Potentially inappropriate prescribing and potential clinically significant drug-drug interactions in older outpatients: is there any association?","volume":"55","author":"Cvetkovi\u0107","year":"2019","journal-title":"Medicina."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2042098619854014","DOI":"10.1177\/2042098619854014","article-title":"Applicability of EU(7)-PIM criteria in cross-national studies in European countries","volume":"10","author":"Fialov\u00e1","year":"2019","journal-title":"Ther Adv Drug Saf."},{"key":"B42","unstructured":""}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.1023171\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T10:25:32Z","timestamp":1671704732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.1023171\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":42,"alternative-id":["10.3389\/fpubh.2022.1023171"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.1023171","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"article-number":"1023171"}}